Early development of the Australia and New Zealand Musculoskeletal Clinical Trials Network.


Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
01 2020
Historique:
received: 12 11 2018
accepted: 02 12 2018
pubmed: 15 12 2018
medline: 5 11 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network was formed to build capacity and infrastructure for high-quality musculoskeletal clinical trials in our region. The purpose of this paper is to describe the steps taken in its formation to help others interested in establishing similar networks. In particular, we describe the steps taken to form the collaboration and our progress in achieving our vision and mission. Our aim is to focus on trials of highest importance and quality to provide definitive answers to the most pressing questions in our field.

Identifiants

pubmed: 30548385
doi: 10.1111/imj.14191
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-23

Subventions

Organisme : National Health and Medical Research Council
ID : Centre of Research Excellence/ APP1134856
Pays : International

Informations de copyright

© 2018 Royal Australasian College of Physicians.

Références

Vos T, Abajobir AA, Abbafati C, Abbafati C, Abbas KM, Abd-Allah F et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 2017; 390: 1211-59.
Australian Institute for Health and Welfare. Chronic musculoskeletal conditions. [updated 2018 Jan 15; cited 2018 Nov 13]. Available from URL: https://www.aihw.gov.au/reports-statistics/health-conditions-disability-deaths/chronic-musculoskeletal-conditions/overview
Arthritis & Osteoporosis Victoria. A Problem Worth Solving: The Rising Cost of Musculoskeletal Conditions in Australia. Melbourne: Arthritis and Osteoporosis Victoria; 2013.
Ackerman I, Bohensky M, Pratt C, Gorelik A, Liew D. Counting the cost. Part 1. Healthcare costs. The current and future burden of arthritis. 2016 [cited 2018 Nov 13]. Available from URL: https://arthritisaustralia.com.au/wordpress/wp-content/uploads/2017/09/Final-Counting-the-Costs_Part1_MAY2016.pdf
Schofield D, Shrestha R, Cunich M. Counting the cost. Part 2: Economic costs. The current and future burden of arthritis. 2016 [cited 2018 Nov 13]. Available from URL: https://www.arthritistas.org.au/wp-content/uploads/2016/05/Final-Counting-the-Costs_Part2_Economic-Costs-MAY2016.pdf
Report by Access Economics Pty Limited for Arthritis New Zealand. The economic cost of arthritis in New Zealand in 2010. 2010 [cited 2018 Nov 13]. Available from URL: https://www.arthritis.org.nz/pdfs/economic-cost-of-arthritis-in-new-zealand-final-print.pdf
Deighton C, Symmons D, Moots R. Musculoskeletal research - opportunities for all? Rheumatology 2012; 51: 1527-8.
Jacobs J, King T, Klippel J, Berven S, Burr D, Caskey P et al. Beyond the decade: strategic priorities to reduce the burden of musculoskeletal disease. J Bone Joint Surg Am 2013; 95: 4.
National Health and Medical Research Council. Research Funding Facts Book 2014. Canberra: Australian Government; 2016 [cited 2018 Nov 13]. Available from URL: https://nhmrc.gov.au/about-us/publications/nhmrc-research-funding-facts-book-2014
The Health Research Council of New Zealand. Research to action. Improving the lives of New Zealanders through health research. HRC Investment Impact Report for the Ministry of Business & Innovation & Employment. 2015 [cited 2018 Nov 13]. Available from URL: http://www.hrc.govt.nz/sites/default/files/Research%20to%20Action%20-%20HRC%20IIR%202015.pdf
Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009; 374: 86-9.
Buchbinder R, Harris I. Arthroscopy to treat osteoarthritis of the knee? Med J Aust 2012; 197: 364-5.
Buchbinder R, Harris I, Sprowson A. Management of degenerative meniscal tears and the role of surgery. BMJ 2015; 350: h2212.
Foster NE, Koes B, Chou R, Peul W, Turner JA, Cohen SP et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 2018; 391: 2368-83.
Robinson P, Taylor W, Dalbeth N. An observational study of gout prevalence and quality of care in a national Australian general practice population. J Rheumatol 2015; 42: 1702-7.
Brand C, Harrison C, Tropea J, Hinman R, Britt H, Bennell K. Management of osteoarthritis in general practice in Australia. Arthritis Care Res 2014; 66: 551-8.
Buchbinder R, Haines T, Ebeling P, Day L, Maher C, Lord S et al. Case for action - proposal to NHMRC. Falls and fracture prevention. 2015 [cited 2018 Nov 13]. Available from URL: https://researchmgt.monash.edu/ws/portalfiles/portal/40686933/40686605_oa.pdf
Australian Clinical Trials Alliance Ltd for the National Health and Medical Research Council. Report on the Activities and Achievements of Clinical Trials Networks in Australia 2004-2014. Canberra: Australian Government; 2015 [cited 2018 Nov 13]. Available from URL: https://www.australianclinicaltrials.gov.au/sites/default/files/files/Report%20on%20the%20Activities%20%20Achievements%20of%20Clinical%20Trials%20Networks%20in%20Australia.pdf
Bourne A, Whittle S, Richards B, Maher C, Buchbinder R. The scope, funding and publication of musculoskeletal trials performed in Australia. Med J Aust 2014; 200: 89-91.
Buchbinder R, Maher C, Harris I. Setting the research agenda for improving the quality of care and value of clinical trials for musculoskeletal disorders. Nat Rev Rheumatol 2015; 1: 597-605.
Day R, Frensham L, Nguyen A, Baysari M, Lau A, Westbrook J et al. Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol. BMJ Open 2017; 7: e017281.
Machado G, Richards B, Needs S, Buchbinder R, Harris I, Howard K et al. Implementation of an evidence-based model of care for acute low back pain in emergency departments: protocol for the SHaPED trial. BMJ Open 2018; 8: e019052.
Bourne AM, Johnston RV, Cyril S, Briggs AM, Clavisi O, Duque G et al. Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open 2018; 8: e023962.

Auteurs

Rachelle Buchbinder (R)

Monash Department of Clinical Epidemiology, Cabrini Institute, Melbourne, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Allison Bourne (A)

Monash Department of Clinical Epidemiology, Cabrini Institute, Melbourne, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Jane Latimer (J)

Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Institute for Musculoskeletal Health, Sydney, New South Wales, Australia.

Ian Harris (I)

Institute for Musculoskeletal Health, Sydney, New South Wales, Australia.
Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, St Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia.

Samuel L Whittle (SL)

Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, St Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia.
The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.

Bethan Richards (B)

Institute for Musculoskeletal Health, Sydney, New South Wales, Australia.
Institute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

William J Taylor (WJ)

University of Otago, Wellington, New Zealand.
Hutt Valley District Health Board, Lower Hutt, New Zealand.
Tairawhiti District Health Board, Gisborne, New Zealand.

Ornella Clavisi (O)

Musculoskeletal Australia, Melbourne, Victoria, Australia.

Sally Green (S)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Rana S Hinman (RS)

Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, The University of Melbourne, Melbourne, Victoria, Australia.

Lyn March (L)

University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia.

Richard Day (R)

Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia.

Manuela L Ferreira (ML)

Institute of Bone and Joint Research, The Kolling Institute, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

Laurent Billot (L)

The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.

Chris G Maher (CG)

Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Institute for Musculoskeletal Health, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH